The incidence of hyponatremia in people using MDMA

This observational invasive trial (n=100) aims to investigate the incidence of (mild) acute hyponatremia in ecstasy users at rave parties.

Led by Universitair Medisch Centrum Utrecht, the study will involve measuring sodium levels in the blood and drug use through urine dipsticks.

Background research suggests that fatal cases of hyponatremia in ecstasy users may represent only a fraction of the actual occurrences, prompting this study to explore potential mild cases with little to no symptoms.

Participants, including at least 50 MDMA users and 50 non-users, will be asked to cooperate anonymously, answer a brief questionnaire, undergo a finger prick for blood sodium level determination, and provide urine samples for drug testing.

All procedures will be conducted anonymously and materials will be destroyed the same night. The study is anticipated to commence in April 2010 and is pending recruitment. Ethical approval has been granted.

Topic Healthy Subjects
Compound MDMA
Country Netherlands
Visit trial
Status Planned
Results Published No
Start date 02 April 2010
End date 30 December 2024
Design Open
Type Interventional
Generation First
Participants 100
Sex All
Age 18- 99
Therapy No

Trial Details

This observational study (n=100) led by Universitair Medisch Centrum Utrecht aims to explore the incidence of mild acute hyponatremia in ecstasy users at rave parties. By measuring blood sodium levels and drug use through urine tests, researchers seek to uncover potential cases with mild or no symptoms. The study, pending recruitment, involves anonymous participation from at least 50 MDMA users and 50 non-users, with procedures conducted in a non-intrusive manner. Ethical approval has been obtained for this anticipated April 2010 trial.

NCT Number NL29997.041.10

Sponsors & Collaborators

Utrecht University
Some researchers at Utrecht University are working on a large psychedelics study with colleagues from Leiden University, but this university hasn't set up any department specifically for psychedelic studies.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.
?>